DiaMedica Therapeutics Inc. , a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases.
Diamedica Therapeutics stock last closed at $2.60, down 4.76% from the previous day, and has increased 6.56% in one year. It has overperformed other stocks in the Biotechnology industry by 0.2 percentage points. Diamedica Therapeutics stock is currently +132.14% from its 52-week low of $1.12, and -17.98% from its 52-week high of $3.17.
There are currently 26.93M shares of DMAC outstanding. The market value of DMAC is $70.03M. In the past 24 hours, 57,934 DMAC shares were traded.
How to Buy Diamedica Therapeutics Stock
Wondering how to invest in Diamedica Therapeutics stock? Here's how.
Choose where to buy Diamedica Therapeutics stock: You need to choose a stock brokerage, but don't worry - we've analyzed dozens of online stock brokerages and apps to help you determine where to buy Diamedica Therapeutics stock.
Sign up for a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
Fund your investment account: Pick your payment method and add your information.
Analyze Diamedica Therapeutics stock: The Diamedica Therapeutics ticker symbol is DMAC. Is Diamedica Therapeutics stock a good investment? Should you buy shares of DMAC? How do DMAC's underlying business fundamentals look? Do top analysts think Diamedica Therapeutics is a good buy? Why has DMAC's stock price moved recently? (Hint: Our stock research tools can help you understand if DMAC is a good stock to buy).
Make your DMAC trade: Decide if you will purchase DMAC shares at the current market price or use a limit order to buy DMAC shares at a particular price.
Get the latest scoop on your investment in DMAC: Create a watchlist to get live updates on your new investment in Diamedica Therapeutics stock.
Step 1: Choose where to buy Diamedica Therapeutics stock
You will need a brokerage account to access the NASDAQ market and buy DMAC shares.
A brokerage account allows you to buy and sell a number of financial instruments, including stocks, bonds, mutual funds, and ETFs.
Our recommended brokerage: eToro
We believe that eToro is the best online stock brokerage. Here's why:
You can invest in stocks with 0% commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
Access to global markets: From Tech to Industrials, New York to Shanghai — you can fill your portfolio with stocks from the world's top stock exchanges.
Social investing: eToro offers a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of other investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by creating an account with eToro now.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Sign up for a brokerage account
Now that you've picked the right brokerage, the next step is to fill out some personal information so you are able to invest in DMAC stock today.
Once you have figured out the best place to buy Diamedica Therapeutics stock, it's crucial to evaluate their stock before you invest, so you actually wrap your head around the risk as well as the upside.
Diamedica Therapeutics Metrics
DMAC Price
$2.60
1w %
-5.45%
1y %
6.56%
5y %
N/A
P/E
-4.41x
P/B
2.59x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$15.36M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$70.03M
Next Earnings
N/A
Next Dividend
N/A
DMAC Zen Score
WallStreetZen was built to help everyday investors perform more accurate fundamental analysis in minutes instead of hours.
Last year, DMAC revenue was $0.00. During the past 4 year, DMAC's revenue has grown by -100% per year. This was slower than the Biotechnology industry average of 90.44%.
No, Diamedica Therapeutics doesn't provide an income stream by paying out dividends.
DMAC Social Trading Data
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Make your DMAC trade
You have two main types of orders:
Market order: A market order is an order to buy or sell a stock at the best price on the market. Market orders are usually fine.
Limit order: A limit order is an order to buy or sell a security at a specific price (or better). If you want to make sure you're buying or selling at a given price limit, use a limit order.
Click the Open button and your broker will place your order.
If you want additional info about investing in stocks on eToro, click the how to video below:
How much does it cost to buy one Diamedica Therapeutics share?
As of Jun 2, 2023, it costs $2.60 to buy one share of Diamedica Therapeutics stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $1, you can buy 0.385 shares of DMAC.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.